Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 27, 2024.
All times in Eastern Daylight Time.
-
agilon health, inc. Investors: May 20, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPRADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. (N... more »
-
Summit Energy Sponsors and Participates in the Interfaith Social Services Stop the Stigma 5KMANSFIELD, Mass.--(BUSINESS WIRE)--Summit Energy, one of the Northeast region’s premier solar installers, is pleased to announce its sponsorship of Interfaith Social Services 50th anniversary of it... more »
-
KIND, KVSB DEADLINE MONDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Investors to Secure Counsel Before Important April 29 Deadline in Securities Class Action – KIND, KVSBNEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NY... more »
-
KB Home Announces a Rare Opportunity to Own a New Townhome in a Prime Ventura, California Location Walking Distance to Popular BeachesVENTURA, Calif.--(BUSINESS WIRE)--KB Home (NYSE: KBH) today announced the grand opening of Seaview at Midtown, a rare opportunity to own a new townhome in a highly desirable Ventura, California loc... more »
-
Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, ... more »
-
Riassunto: ReNAgade Therapeutics conferma il proprio impegno verso GanNA Bio e la biologia dei glicaniCAMBRIDGE, Mass.--(BUSINESS WIRE)--ReNAgade Therapeutics, azienda impegnata nello sviluppo del potenziale illimitato dei farmaci a base di RNA, oggi annuncia che continuerà a impegnarsi nell'esplor... more »
-
ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続米マサチューセッツ州ケンブリッジ--(BUSINESS WIRE)--(ビジネスワイヤ) -- RNA医薬品の無限の可能性にチャレンジする企業であるReNAgadeセラピューティクスは、GanNA Bioで現在進めている研究を支援し、同社のキーパーソンをReNAgadeのエコシステムに迎え入れることで、糖鎖生物学を活用した治療機会の探求に継続的に取り組むことを発表しました。GanNAの創設者... more »
-
ReNAgade Therapeutics poursuit son engagement auprès de GanNA Bio et de la biologie des glycanesCAMBRIDGE, Massachusetts--(BUSINESS WIRE)--ReNAgade Therapeutics, une société qui exploite le potentiel illimité des médicaments à base d’ARN, a annoncé aujourd’hui son engagement continu à explore... more »
-
ReNAgade Therapeutics setzt Engagement für GanNA Bio und Glykobiologie fortCAMBRIDGE, Massachusetts--(BUSINESS WIRE)--ReNAgade Therapeutics, ein Unternehmen, das das grenzenlose Potenzial von RNA-Medikamenten erschließt, gab heute sein anhaltendes Engagement für die Erfor... more »
-
HCLテクノロジーズ、2024年度の売上高は前年比5.4%増の133億ドルを計上ニューヨーク&印ノイダ--(BUSINESS WIRE)--(ビジネスワイヤ) -- 世界有数のテクノロジー企業であるHCLテクノロジーズは、2024年3月31日に終了した第4四半期および通期の決算を発表しました。 当社の通年の売上高は、前年比5.4%増の133億ドルとなりました。デジタル・サービスの売上高は5.3%増加(恒常為替レート・ベース)し、現在ITサービス売上高全体の37.3%を占... more »
-
HCLTech报告2024财年收入为133亿美元,同比增长5.4%纽约和印度诺伊达--(BUSINESS WIRE)--(美国商业资讯)-- 全球领先的科技公司HCLTech今天公布了第四季度和截至2024年3月31日的全年财务业绩。 该公司报告全年收入为133亿美元,同比增长5.4%。数字服务收入增长了5.3%(按固定汇率计算),目前占IT服务收入的37.3%。 HCLSoftware的年度经常性收入为10.2亿美元。 2024财年,该公司赢得了73笔大... more »
-
HCLTech 稱 2024 會計年度收益為 133 億美元,較去年同期成長 5.4%紐約和印度諾伊達--(BUSINESS WIRE)--(美國商業資訊)-- 世界領先的科技公司 HCLTech 今天公布了截至 2024 年 3 月 31 日的第四季度和全年財務業績。 該公司報告表示,全年收益為 133 億美元,年營收增長率上升 5.4%。數位服務收益成長了5.3%(CC),目前佔 IT 服務收益的 37.3%。HCLSoftware 的年度經常性收益為 10.2 億美元。... more »
-
HCLTech rapporteert omzet voor boekjaar 24 van $ 13,3 miljard, een stijging van 5,4% op jaarbasisNEW YORK & NOIDA, India--(BUSINESS WIRE)--HCLTech, een toonaangevend internationaal technologiebedrijf, rapporteerde vandaag financiële resultaten voor het vierde kwartaal en het volledige jaar ein... more »
-
Riassunto: HCLTech riferisce un fatturato di 13,3 miliardi per l'esercizio 2024, con un rialzo del 5,4% su base annuaNEW YORK e NOIDA, India--(BUSINESS WIRE)--HCLTech, tra le società globali leader nel comparto tecnologico, oggi ha dichiarato i risultati finanziari per il quarto trimestre e l'intero esercizio ter... more »
-
ReNAgade Therapeutics繼續致力於GanNA Bio和糖生物學的研究麻薩諸塞州劍橋--(BUSINESS WIRE)--(美國商業資訊)-- ReNAgade Therapeutics是一家致力於開發RNA藥物無限潛力的公司。該公司今天宣布,將繼續致力於透過支援GanNA Bio的持續研究以及將GanNA Bio的關鍵單品整合到ReNAgade生態系統中,探索糖生物學的治療潛力。GanNA創辦人Carolyn Bertozzi博士和Richard D. Cu... more »